product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
NMDAR2B Antibody
catalog :
4207
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; rat; 1:1000
Liu X, Liu Y, Zhang J, Zhang W, Sun Y, Gu X, et al. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord. Brain Res Bull. 2014;106:9-16 pubmed publisher
Fan M, Xu H, Wang L, Luo H, Zhu X, Cai P, et al. Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13. Sci Rep. 2016;6:25971 pubmed publisher
Burgdorf J, Zhang X, Colechio E, Ghoreishi Haack N, Gross A, Kroes R, et al. Insulin-Like Growth Factor I Produces an Antidepressant-Like Effect and Elicits N-Methyl-D-Aspartate Receptor Independent Long-Term Potentiation of Synaptic Transmission in Medial Prefrontal Cortex and Hippocampus. Int J Neuropsychopharmacol. 2015;19: pubmed publisher
product information
SKU :
4207S
Product-Name :
NMDAR2B Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Western blot
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
190
Host :
Rabbit
Target :
NMDAR2B
Primary-Protein :
NMDAR2B
Alt-Names :
GRIN2B,Glutamate [NMDA] receptor subunit epsilon-2,MGC142178,MGC142180,N-methyl D-aspartate receptor subtype 2B,N-methyl-D-aspartate receptor subunit 3,NMDAR2B,NMDE2,NR2B,NR3,glutamate receptor subunit epsilon-2,glutamate receptor, ionotropic, N-methyl D-aspartate 2B,hNR3
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.